Correlation Between ANI Pharmaceuticals and Catalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and Catalent, you can compare the effects of market volatilities on ANI Pharmaceuticals and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Catalent.

Diversification Opportunities for ANI Pharmaceuticals and Catalent

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between ANI and Catalent is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Catalent go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and Catalent

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to under-perform the Catalent. In addition to that, ANI Pharmaceuticals is 2.59 times more volatile than Catalent. It trades about -0.04 of its total potential returns per unit of risk. Catalent is currently generating about 0.18 per unit of volatility. If you would invest  5,909  in Catalent on August 26, 2024 and sell it today you would earn a total of  189.00  from holding Catalent or generate 3.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ANI Pharmaceuticals  vs.  Catalent

 Performance 
       Timeline  
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Catalent 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Catalent is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

ANI Pharmaceuticals and Catalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANI Pharmaceuticals and Catalent

The main advantage of trading using opposite ANI Pharmaceuticals and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.
The idea behind ANI Pharmaceuticals and Catalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes